AI use in breast radiology increased cancer detection without higher recall rates, according to a 100,000+ case multicenter study.
Key Details
- 1Study conducted across four sites and included nine experienced breast radiologists.
- 2Over 100,000 digital breast tomosynthesis (DBT) exams analyzed.
- 3Results compared pre- and post-AI implementation: 54,000 exams before AI (339 true positives) vs. nearly 49,000 with AI (369 true positives).
- 4AI improved invasive and dense breast cancer detection and lowered average diagnosis stage.
- 5No increase in recall rates was observed with AI usage.
- 6The AI tool was provided by iCAD and the DBT system by GE HealthCare.
Why It Matters
Demonstrates AI's practical benefits in increasing breast cancer detection while maintaining recall rates, addressing workload and burnout concerns. This adds impactful real-world data supporting AI adoption in radiology practices.
Source
Radiology Business
Related News
•Radiology Business
RadNet AI Tool Reduces Unnecessary Prostate Biopsies by 19%
RadNet's DeepHealth AI tool can help avoid nearly 1 in 5 prostate biopsies while maintaining high cancer detection sensitivity.
•Radiology Business
Everlywell Launches Direct-to-Consumer Mammography AI for Breast Cancer Risk
Everlywell now offers the FDA-authorized Clairity Breast AI tool for patients to assess breast cancer risk from their mammograms.
•Radiology Business
GE HealthCare Appoints Chief AI Officer to Lead Imaging Innovation
GE HealthCare has hired Rodolphe Katra as its new global chief AI officer to drive its AI strategy in imaging.